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Abstract
Background: The objective of this study was to assess efficacy and determine the optimal indication of selective arterial
embolisation (SAE) in patients with life-threatening post-partum haemorrhage (PPH).
Methodology/Principal Findings: One hundred and two patients with PPH underwent SAE and were included from January
1998 to January 2002 in our university care center. Embolisation was considered effective when no other surgical procedure
was required. Univariate and multivariate statistical analysis were performed. SAE was effective for 73 patients (71.5%), while
29 required surgical procedures. SAE was effective in 88.6% of women with uterine atony that was associated with positive
outcome (OR 4.13, 1.35–12.60), whereas caesarean deliveries (OR 0.16, 0.04–0.5) and haemodynamic shock (OR 0.21, 0.07–
0.60) were associated with high failure rates, 47.6% and 39.1%, respectively.
Conclusions/Significance: Success rate for SAE observed in a large population is lower than previously reported. It is most
likely to succeed for uterine atony but not recommended in case of haemodynamic shock or after caesarean section.
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Introduction
Post-partum haemorrhage (PPH) occurs in 2–11% of deliveries,
remains a major cause of maternal mortality and morbidity,
despite advances in obstetrics and intensive care.[1,2] In
developed countries, life-threatening PPH occurs in 1 per 1000
deliveries;[3–5] it is the main cause of maternal mortality in
France, responsible for more than 20 of the 80 maternal deaths
each year [1,2]. Prevention and rapid identification of the source
and control of the bleeding are essential to prevent maternal
morbidity and mortality [6,7]. In most cases PPH can be managed
medically with such uterotonic drugs as oxytocin or prostaglandin
analogues [4,8]. When medical treatment remains insufficient,
three therapeutic options are available. The two standard
alternatives are vascular ligature (e.g., of the hypogastric or
uterine arteries) [3,9], with success rates ranging from 40% to
100% [10–15], and emergency hysterectomy, which is the
treatment of last resort for PPH [3]. Selective arterial embolisation
(SAE) of the uterine arteries was recently proposed as an
alternative to surgery, and success rates for controlling severe
PPH with it are reported to range from 85% to 95% [13,16]. Its
benefits seem to include a low complication rate and the avoidance
of the risks of surgery and general anaesthesia in haemodynam-
ically unstable patients [13,17].
The studies evaluating SAE so far, however, have two major
methodological drawbacks: relatively few patients (9 to 35) and
imprecise descriptions of the severity of the PPH and of the
patients’ general status [13,16].
The aim of our study was to assess the efficacy and determine
the optimal indication for SAE in the management of severe life-
threatening PPH in a large population.
Methods
Objectives
The objective of our study was to assess the efficacy and
determine the optimal indication for SAE in a large population of
patients with severe life-threatening PPH.
Participants
This study included all women who had life-threatening
primary PPH and underwent SAE in our university teaching
hospital from January 1998 through January 2002. They either
gave birth in our obstetrics department or were transferred from
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a vascular imaging unit. Severe PPH was defined as a blood loss
greater than 1500 cc and either haemodynamic shock (defined by
the need for continuous perfusion of vasopressors) or disseminated
intravascular coagulation (platelet count ,50 000 per mm
3,
elevated prothrombin time, defined as greater than twice the
control values, hypofibrinogenemia, defined as less than 150 mg/
dl, and a prothrombin rate less than 50%), or both. Blood loss was
estimated by collection bag which was systematically placed at the
end of the delivery. For the patients transferred from other
institutions, we added the estimated blood loss evaluated by the
medical team of the hospital of origin with the estimated blood loss
in our hospital.
Description of Procedures or Investigations undertaken
All patients were treated according to the same treatment
protocol for PPH, summarised in the decision algorithm approved
by the three departments involved in this study (Figure 1).
Anaesthesiology management in the intensive care unit included
initial evaluation and resuscitation. Patients were monitored with
continuous oximetry, heart rate and blood pressure, indwelling
urinary catheter for hourly urine output measurements, and
femoral venous and arterial catheters. Resuscitation involved fluid
(colloids and crystalloids) replacement and blood and plasma
transfusion responsive to laboratory results. In case of uncontrolled
hypotension, continuous norepinephrine infusion was started on
the femoral line. Mechanical ventilation was initiated in case of
uncontrolled haemorrhagic shock with neurological failure. For
sedation we used midazolam and sufentanil or ketamine in case of
severe shock. Amoxicillin and clavulanic acid were systematically
administered for antibiotic prophylaxis.
Basic obstetrical management for patients with vaginal delivery
involved bimanual uterine examination, removal of any retained
placental parts or membranes, and careful inspection of the genital
tract for lacerations or tears. Any surgical tears was repaired before
performing the SAE. Patients who had caesarean deliveries
underwent abdominal ultrasound to verify the absence of retained
placental pieces in the uterus and to rule out hemoperitoneum.
Medical management included uterine massage, intravenous
diluted oxytocin up to a cumulative dose of 55 IU (Syntocinon;
Sandoz, Reuil-Malmaison, France) and sulprostone, a prostaglan-
din-E2 analogue (a first injection of 500 mg over an hour and a
Figure 1. Decision algorithm for treatment of post-partum haemorrhage by selective arterial embolisation in our institution.
doi:10.1371/journal.pone.0003819.g001
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Lys-les-Lannoy, France).
After obstetrical evaluation patients were transferred under
close monitoring to the vascular imaging department for SAE.
Resuscitation continued during SAE. The vascular radiologist
performed emergency digital subtraction angiography with an
unilateral femoral approach. In most cases contralateral internal
iliac angiography and selective study of the anterior division then
followed, always with a 5-F cobra catheter and a hydrophilic
polymer-coated 0.032-inch guide wire (Radiofocus; Terumo) to
analyse the uterine arteries. Super-selective study of the uterine
artery was attempted in all cases. Other anastomotic vessels,
including the vaginal, ovarian and round ligament arteries, were
studied when necessary. The ipsilateral internal iliac artery was
then catheterised by the same puncture site and the same cobra
catheter. Absorbable gelatin sponge pledgets were injected as
embolisation agents under fluoroscopic guidance. Bilateral embo-
lisation was attempted in all patients. When the uterine artery
could not be selectively catheterised, the anterior division of the
hypogastric artery was embolised instead. Post-embolisation
angiography was performed to verify the complete occlusion of
the vessels.
All patients were transferred to the surgical intensive care unit
for at least 24 hours for further observation and coagulation
studies with the femoral artery sheath left in place until
achievement of haemodynamic stability, correction of coagulation
disorders and complete cessation of the haemorrhage.
In this study we considered SAE effective when bleeding
stopped after the procedure. The embolisation was considered
ineffective when any additional surgical procedure was necessary
to stop the bleeding completely.
Data extracted from the patients’ records included individual
and obstetric characteristics (maternal age, parity, mode and term
of delivery, cause of PPH), as well as those relevant to critical care,
haemostasis and coagulation (shock, disseminated intravascular
coagulation, mean haemoglobin level, mean platelet count, mean
prothrombin time, mean partial thromboplastin time expressed as
ratio to control values, mean number units of whole blood, fresh
frozen plasma and platelets transfused).
Ethics
The French Research Ethics Committee chair stated that
approval for this study was not required.
Statistical methods
Results are expressed as means6SE. We used univariate
procedures (Student’s t test or chi-square test, as appropriate) to
test possible associations of laboratory findings and clinical
parameters with the embolisation results. We first analysed the
relation between the patients’ characteristics (e.g., causes of PPH)
and SAE results and then that between the critical care-related
variables and SAE outcome. To estimate the independent
predictive value of each variable, they were all analysed in a
multivariate procedure with stepwise logistic regression (Biomed-
ical Data Processing Package, University of California, Los
Angeles, California). Conservative criteria were used to select
variables (p value of 5% required for entry into or removal from
model) and the ratio between the regression coefficient for each
factor and its standard error had to exceed 2.
Results
During the study period 102 patients were treated with SAE
and enrolled in the study: 12 (11.7%) gave birth in the obstetrics
department of our institution and 90 (88.3%) patients were
transferred from other obstetrics units.
Patients’ Characteristics
Table 1 reports the women’s obstetrical characteristics. PPH
was caused by uterine atony (N=44, 43.1%), cervical or vaginal
tears (N=20, 19.6%), abnormal placentation (including placenta
accreta and percreta) (N=14, 13.6%), vaginal thrombus (N=11,
10.7%), intrauterine retention (N=7, 6.8%), abruptio placentae
(N=4, 3.9%) and repaired uterine rupture, (N=2 , 1.9%).
Overall, 46 (45%) patients had haemodynamic shock, and 59
(57.8%) disseminated intravascular coagulation. At admission, the
mean haemoglobin level was 6.0361.6 dg/l (1.8–10.5), mean
platelet count 81 698646 740 (28 000–240 000), mean
prothrombin rate 42.7618.3 (5–90) and mean partial thrombo-
plastin time (relative to control values) 2.1561.8 . The mean
number of units of whole blood transfused was 8.666.3 (1–31), of
fresh frozen plasma 3.564.3 (0–23) and of platelets 1.0263.5 (0–
14) respectively. Three women required emergency management
of cardiac arrest.
SAE of both uterine arteries was performed in 57 (55.8%) cases,
SAE of one uterine artery and embolisation of the contralateral
anterior branch of the hypogastric artery in 24 (23.5%), and
bilateral embolisation of the anterior branch of the hypogastric
artery in the other 21 (20.5%). Other vessels were embolised in six
(5.8%) women: 4 (3.9%) the cervicovaginal arteries, and 1 each
(0.8%) the ovarian anastomosis and the round ligament artery.
Two women died during in this study. The first patient was
29 years old, gravida 7, para 3, with past medical history of pre-
eclampsia (in 5 previous pregnancies) and intrauterine death (in 3).
Caesarean delivery took place under general anaesthesia at 28
weeks’ gestation, for severe pre-eclampsia. She was transferred to
our surgical intensive care unit, after C-section, for persistent
diffuse bleeding. At admission, her haemoglobin level was 8.4 dg/
l, her platelet count 63 000, prothrombin rate 24%, and fibrinogen
35 mg/dl. Major shock followed, with bilateral mydriasis;
haemoglobin dropped to 4.9 dg/l. She received 6 units of whole
Table 1. Maternal and obstetrical characteristics of the
patients.
Age
Mean6Standard Deviation 31.8 years65.9
Range 21–45 years
Parity
Mean6Standard Deviation 2.0161.11
Range 1–6
Term of Delivery
Mean6Standard Deviation 38.362,9 weeks
Range 28 to 42 weeks
Multiple pregnancies (twin) n (%) 4 (3.9%)
Mode of delivery
Vaginal delivery n (%) 82 (79.4%)
- Forceps delivery n (%) 28/81 (34.5%)
Caesarean delivery n (%) 22 (20.6%)
Birth Weight
Mean6Standard Deviation 3263.46546.6
Range 2120–4751
doi:10.1371/journal.pone.0003819.t001
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transferred to radiology department for SAE. Her haemodynamic
status remained stable under continuous perfusion of norepineph-
rine during and after SAE. At this point computed tomography of
the brain showed a cerebral haemorrhage with intraventricular
bleeding, although gynaecological bleeding had stopped by then.
After a day in the ICU, two electroencephalograms revealed no
cerebral activity; she died the next day.
The second patient, aged 38 years, gravida 4, para 4, had
vaginal delivery followed by PPH due to cervicovaginal tears, that
persisted despite immediate surgical repair and vaginal packing.
Cardiorespiratory arrest ensued three hours later, requiring
resuscitation and transfusion of 6 whole blood units. After transfer
to our department, electrocardiac activity continued but circula-
tory activity was insufficient. We performed SAE of left uterine
artery and right anterior branch of the hypogastric artery. Because
of continued bleeding and haemodynamic instability, a hysterec-
tomy followed, with the vaginal tear repaired during aortic cross-
clamping. While bleeding stopped after surgery, severe multiorgan
failure had already occurred, and she died 30 hours after delivery.
Outcome of SAE
SAE was effective for 73 patients (71.5%), 14 (13.7%) of whom
required a second embolisation during the first 24 hours. The
other 29 women required surgery. These included 9 laparotomies
with focused limited haemostasis, 7 hysterectomies, 2 uterine
artery ligations, and 11 genital tear repairs. In these latter
procedures SAE was performed after reparation of any genital
tears however 11 patients had still persistent bleeding after initial
repair and SAE thus requiring a second surgery. SAE led to a
reduction of pelvis blood flow that might have increased the
efficiency of secondary surgery.
General complications included cardiogenic pulmonary oede-
mas related to the haemorrhage in 5 women, transient renal
failure in 7, one of whom subsequently developed cortical necrosis
and end-stage renal failure, and myocardial ischaemia in 3. Local
complications included ischaemia of the lumbar plexus in one
patient, and gluteal pain persisting 4 months in another. The
mean duration of stay in the intensive care unit was 2.0761.2 days
(1–6.2).
The factors significantly associated to embolisation success or
failure are represented in Table 2. The univariate analysis showed
that mode of delivery was correlated with successful SAE: it was
successful for 63 of 81 (77.7%) with vaginal deliveries, compared
with 11 of 21 patients with caesarean births (52.7%) (p=0.017).
We also analysed the role of different causes of PPH on the
outcome of SAE: uterine atony was associated with high rate of
success (39 of 44 patients, 88%) (p,0.005). Efficacy of SAE did not
differ according to the other causes, but vaginal and cervical tears
had a trend towards lower success rates: 9 failures in 20 patients
(45%)(p=0.06). Of the other characteristics considered, failure
was significantly associated with shock (18 failures among 46
patients, 39.1%, p=0.02).
When we used multivariate analysis to examine factors that
predicted success of arterial embolisation, three variables were
significant: good outcome was associated with uterine atony (odds
ratio (OR 4.13 (95% CI, 1.35–12.6)), while poor outcome was
associated with caesarean delivery (OR 0.16 (95% CI, 0.04–0.5))
and with shock (OR 0.21 (95% CI, 0.07–0.6)).
Discussion
Efficiency of SAE was 71.5% in the whole study population.
Uterine atony that was associated with positive outcome with an
overall success rate of 88.6% (OR 4.13, 1.35–12.60). However,
caesarean deliveries (OR 0.16, 0.04–0.5) and haemodynamic
shock (OR 0.21, 0.07–0.60) were associated with higher failure
rates, 47.6% and 39.1%, respectively.
SAE is a non-surgical, minimally invasive method of uterine
devascularisation [13]. Over the past five years, this technique has
become widely used in the treatment of PPH in France [16,18].
Previous studies have reported low morbidity and excellent success
rates for SAE, ranging from 85% to 95% [13,16,18]. The
literature so far nonetheless has several limitations. Most of the
studies are retrospective, and the two largest prospective studies
include only 27 and 35 patients [16,18]. The 71% success rate we
report here is lower than the rates reported in previous studies. We
included all patients with severe life-threatening PPH. All these
patients were admitted to the intensive care unit because of
haemodynamic instability or severe coagulopathy. The severe
condition of the patients in this study may explain this lower
success rate. Moreover, the patients described in other studies
were treated during the development of the technique since these
promising results, not only the indications for SAE have been
extended to PPH after caesarean delivery, vaginal or cervical tears,
but the severity of illness of the patients treated is more important
than the patients in the preliminary studies.
Limitations
One of the major limitation of the haemodynamic parameter is
the difficulty to exactly assess the boold Loss. The use of a
systematic collection bag is part of the recommendation of the
french college of Obstetrics and Gynecology. However it probably
underestimate the real blood loss. This study reports results of SAE
performed by 7 different radiologists, compared with only 4 in our
previous report [16,18]: the reproducibility of the technique may
also be responsible for the lower success rate and this matter
deserve an evaluation, the number of cases in this study was not
enough to reach statistical significance regarding clinical perfor-
mances of the different radiologist. Most of the patients of the
current study were transferred from other obstetrics units, because
of the severity of their illness. This might have affected their
Table 2. Factors significantly associated to embolisation success or failure.
Factors Successful embolisation (N=73) Unsuccessful embolisation (N=29) P (CI)
Vaginal delivery 63/73 (86.3%) 18/29 (62%) 0.01
Caesarean 11/73(15%) 10/29 (34%) 0.01
Uterine atony 39/73 (53%) 5/29 (17.2%) ,0.001
Vaginal and/or cervical tears 11/73 (15%) 9/29 (31.%) 0.06
Haemodynamic shock 28/73 (38.3%) 18/29 (62%) 0.02
doi:10.1371/journal.pone.0003819.t002
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organization of peri-natal care worldwide will not allow the setting
of technical facilities for SAE in all hospitals, and patient’s transfer
will therefore be a necessity in most cases.
Vaginal delivery was associated with a higher success rate than
was caesarean delivery (77.7% and 47.5% respectively, p,0.05).
Of the causes of PPH, uterine atony was associated with the
highest success rate (88.6%). Vaginal or cervical tears were
associated with a trend towards SAE failure (p=0.06). Shock was
also associated with a significantly lower success rate: SAE failed in
28 of 72 (38.3%) patients with shock. Disseminated intravascular
coagulopathy was not correlated with SAE outcome.
Severe PPH is a complex situation, often involving a
combination of characteristics (mode of delivery, PPH causes,
and haemodynamic and coagulation status). Accordingly we
conducted a multivariate analysis to identify independent factors
that may influence SAE outcome.
Uterine atony remains an independent predictor of SAE success
in the multivariate analysis, with an odds ratio of 4.13 (95% CI,
1.35–12.6). Caesarean delivery was correlated with poor results,
with an odds ratio of 0.16 (95% CI, 0.04–0.5). Surgical methods,
in particular uterine artery ligation, have been shown to be
successful and may thus be more appropriate for PPH after
caesareans [3,13,19]. The causes of PPH after caesarean are
different from causes after vaginal delivery: for example, only
22.7% of the PPH in the caesarean group were due to uterine
atony, compared with 48.1% in the vaginal delivery group
(p=0.03). Similarly, 40.9% of the haemorrhages after caesareans
were due to abnormal placentation 40.9% but only 8.6% for the
vaginal delivery group (p,0.003). These differences in the causes
of PPH can explain the discrepancy of the oucome of SAE.
Shock was also a negative predictor of SAE success: the OR was
0.21 (95% CI, 0.07–0.6). Although SAE can be used in
haemodynamically unstable patients as surgery can be more
challenging for these patients, anything that may delay treatment
and foreclose options for these patients should be avoided.
Emergency hysterectomy must always be considered an option
in this life-threatening situation.
We reported two deaths in this study. The causes of PPH in
those cases were surgical (one occurred after a caesarean delivery
and the other was caused by genital tears. As the case descriptions
make clear, these patients were in extremely grave condition at the
time of the SAE. The first patient stopped bleeding after the SAE,
but the second required a hysterectomy. The procedure itself did
not change these patients’ outcome. Both, however, were
transferred to our institution for SAE, and we must wonder
whether this medical transfer was justified, or if it delayed optimal
surgical management.
Recent studies report a return of normal menses and
preservation of future fertility with successful uneventful pregnan-
cies after SAE [20–22]. However, we focused on outcome of SAE
in severe PPH. Our study is the first large trial to assess the results
of SAE in treating life-threatening PPH in a large population. It
suffers from methodological and statistical limitations because it
was neither controlled nor randomised, but it is extremely difficult
to conduct such a trial in this rare, life-threatening emergency
situation. The success rate in a large population with extremely
severe PPH is not as good as the overall rates reported in the
literature. PPH due to uterine atony after vaginal delivery remains
an optimal indication for SAE; caesarean deliveries and
hemodynamic shock are not associated with good success rates.
Several reports have confirmed the efficacy of uterine artery
ligature in the treatment of PPH after caesarean [3,13,19].
Whether surgery should be preferred to SAE is still unknown.
However it seems very difficult for both ethical and technical
reasons to organize a randomised controlled trial in such a life-
threatening disease that need immediate management. However
as SAE does not always guarantee haemostasis in cases of severe
PPH; the indications of transfer if needed for this treatment should
be carefully discussed in light of the patient’s haemodynamic status
to minimise the risks.
In conclusion, SAE appears to be an effective method for
treating PPH, but the situations in which SAE or surgical
treatments such as vascular ligature or emergent hysterectomy
are indicated should be clarified with a larger clinical trial.
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